Intensity Therapeutics Inc. (INTS)
(Real Time Quote from BATS)
$0.29 USD
0.00 (-1.02%)
Updated Aug 6, 2025 10:00 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Intensity Therapeutics Inc. has a market cap of $7.35M, which represents its share price of $0.29 multiplied by its outstanding shares number of 25.07M. As a small-cap company, INTS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
INTS 0.29 0.00(-1.02%)
Will INTS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for INTS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INTS
Is Cencora, Inc. (COR) Outperforming Other Medical Stocks This Year?
Has Cencora, Inc. (COR) Outpaced Other Medical Stocks This Year?
INTS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for INTS
Intensity Therapeutics raises $6.6M via at-the-market offering
Intensity Therapeutics (INTS) Raises $6.6M Through At-the-Market Offering
Intensity Therapeutics, Inc. Raises $6.6 Million from At The Market Offering (ATM) Stock Sales ...
Intensity Therapeutics raises $6.6M from ATM stock sales in July
Intensity Therapeutics (INTS) Receives Buy Rating Amid Clinical Shift